Katten Muchin Rosenman has advised Processa Pharmaceuticals, Inc. Cooley has advised Vidya Therapeutics, Inc. Mintz has advised the placement agents. Processa Pharmaceuticals, Inc. (NASDAQ: PRCT) has...
Processa Pharmaceuticals Acquires Vidya Therapeutics and Announces $200 Million Private Placement
LB Pharmaceuticals Completes $150 Million Private Placement of Common Stock and Pre-Funded Warrants
Cooley LLP has advised LB Pharmaceuticals Inc. Mintz has advised Leerink Partners and Piper Sandler as placement agents. LB Pharmaceuticals Inc. (Nasdaq: LBRX) has announced the...
uniQure Completes $259 Million Public Offering of Ordinary Shares
Morgan, Lewis & Bockius LLP, NautaDutilh N.V., Van Campen Liem, Nederlandsch Octrooibureau, and Clark & Elbing, LLP have advised uniQure. Mintz has advised the underwriters. uniQure...
NervGen Pharma Completes $60 Million Public Offering
Joseph Garcia from Blake, Cassels & Graydon LLP has advised NervGen Pharma. Mintz has advised the underwriters. NervGen Pharma has completed a public offering valued at...
Avalo Therapeutics Launches $430 Million Public Offering of Common Stock and Warrants
Goodwin Procter LLP has advised Avalo Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a...
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering
Mintz and Stikeman Elliott LLP have advised the underwriters. Troutman Pepper and Blake, Cassels & Graydon LLP have advised Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical-stage...
Satellos Bioscience Completes US$57.2 Million Cross-Border Public Offering and Nasdaq Listing
Mintz has advised Satellos Bioscience Inc. Latham & Watkins has represented the underwriters. Satellos Bioscience Inc., a clinical-stage biotechnology company, has completed a US$57.2 million underwritten...
Fulcrum Therapeutics Prices $175 Million Public Offering of Stock and Pre-Funded Warrants
Goodwin Procter LLP has advised Fulcrum Therapeutics. Mintz has advised the underwriters. Fulcrum Therapeutics, Inc. (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company, has announced the pricing...
Wave Life Sciences Announces $402.5 Million Public Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, WongPartnership, and Choate Hall & Stewart have advised Wave Life Sciences. White & Case has advised the underwriters. Wave...
Capricor Therapeutics Completes $172.5 Million Public Offering of Common Stock
Sidley Austin has advised Capricor Therapeutics. Mintz has advised the underwriters. Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company, has completed an underwritten public offering of...
Cogent Biosciences Announces $230 Million Convertible Senior Notes Offering
Gibson Dunn has represented Cogent Biosciences, Inc., and Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT) has announced the pricing of its underwritten public...